1. Lu, Feng, Zhou, Jing, Chen, Qing, Fang, Na, Qiao, Ling. . PSMA5 contributes to progression of lung adenocarcinoma in association with the JAK/STAT pathway. In Carcinogenesis, 43, 624-634. doi:10.1093/carcin/bgac046. https://pubmed.ncbi.nlm.nih.gov/35605971/
2. Gao, Feng, Wang, Zhengzheng, Gu, Jiajie, Zhang, Xiaojia, Wang, Huixiao. 2021. A Hypoxia-Associated Prognostic Gene Signature Risk Model and Prognosis Predictors in Gliomas. In Frontiers in oncology, 11, 726794. doi:10.3389/fonc.2021.726794. https://pubmed.ncbi.nlm.nih.gov/34868920/
3. He, Huiling, Yang, Yingxia, Wang, Lingxing, Ou-Yang, Wanjiong, Yang, Meili. 2023. Combined analysis of single-cell and bulk RNA sequencing reveals the expression patterns of circadian rhythm disruption in the immune microenvironment of Alzheimer's disease. In Frontiers in immunology, 14, 1182307. doi:10.3389/fimmu.2023.1182307. https://pubmed.ncbi.nlm.nih.gov/37251379/
4. Fu, Zhenrui, Lu, Chao, Zhang, Changwen, Qiao, Baomin. . PSMA5 promotes the tumorigenic process of prostate cancer and is related to bortezomib resistance. In Anti-cancer drugs, 30, e0773. doi:10.1097/CAD.0000000000000773. https://pubmed.ncbi.nlm.nih.gov/30807553/